VALERIE HENSHAW: Open Payments
NPI 1598478430 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 4 payments from 4 companies in 2025. Trend: 2023 $2,293 · 2024 $1,540 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $135 |
| Novo Nordisk Inc | 1 | $120 |
| ABBVIE INC. | 1 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
Products named: BREZTRI, Wegovy, VRAYLAR, UPTRAVI.
Industry payments across MD — which companies pay providers there.
